STAT Plus Novo Nordisks Jorgensen If it was easy to correct pricing we would be doing it already

STAT Plus: Novo Nordisk’s Jorgensen: If it was easy to correct pricing, we would be doing it already

09:25 EDT 2 Jul 2019 | STAT

"The patient ends up paying three times compared to what the company gets," says Novo Nordisk CEO Lars Fruergaard Jorgensen. "That’s an absurd system."

STAT Plus Novo Nordisks Jorgensen If it was easy to correct pricing we would be doing it already

STAT Plus: Novo Nordisk’s Jorgensen: If it was easy to correct pricing, we would be doing it already

More From BioPortfolio on "STAT Plus: Novo Nordisk’s Jorgensen: If it was easy to correct pricing, we would be doing it already"